u/diego_sorensen

National regulatory approval establishes that a product may be sold. Whether any plan pays for it is a separate decision, and public drug plans are administered provincially.

draw at the same point in the week if you want comparability

What did the repeat show?

write down when it starts and stops, the pattern is the useful part

My ALT moved and I spent a fortnight convinced I knew why. The repeat six weeks later was back in range and I had changed nothing.

Quantity limits restrict how much may be dispensed in a period even where coverage exists. They are a distinct barrier and require a distinct request.

ApoB is the one worth adding if you only add one

I would push back gently. Going up because the scale paused is the single most common mistake described on this board.

Constipation is mostly reduced intake plus reduced fluid, not a direct effect. That is why the boring fibre and water answer keeps working.

hair shedding follows the weight loss, not the drug, and it stops

I would push back gently. Going up because the scale paused is the single most common mistake described on this board.

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.

Same lab as the previous draw?

Cosigning on quantity limits. They stop as many people as outright denials do and get discussed far less.

What did week 49 look like compared with this one? The month either side is the useful comparison.

lab reference ranges are not treatment targets

Most of the common complaints trace back to slowed gastric emptying — early fullness, reflux, nausea after a large or fatty meal. That is also why meal size and speed change the experience more than anything else.

ask whether the lab changed its assay between your two draws

Which province?

Sceptical of the mechanism you are proposing. Gastric emptying slows, it does not stop, and the timings you describe do not follow from it.

Time of day, fasting state, hydration and recent exercise all move common markers. Standardising the draw conditions is free and it removes most of the apparent variability.

Push back: approval by the national regulator says nothing about whether any plan will pay.

Correction: that is a known effect of reduced intake rather than a direct drug effect. The distinction matters because the fix is different.

the same product can be covered in one province and not the next

the scale is the least sensitive instrument you own

Correct, and worth adding: the trial average is an average. Half the people in it did worse than 15% and were still on the drug.

Most of the common complaints trace back to slowed gastric emptying — early fullness, reflux, nausea after a large or fatty meal. That is also why meal size and speed change the experience more than anything else.

A rejected claim at the pharmacy counter and a denied authorization are different events with different remedies. The first can be an administrative or quantity issue; the second is a determination you can appeal.

Severe or persistent abdominal pain sits outside the pattern this board can usefully discuss. The honest answer there is that it needs someone who can examine you.

Research-use-only material is not approved for human use, so anything in this thread about how a compounded or research vial "should" behave is a chem

Right, and the timescale is the bit that keeps getting lost. Judge a step at a month, not at a weekend.

Nothing in this thread is medical advice, including this comment. I am describing a mechanism, not telling anybody what to do about their own week.

Genuine question — is the appetite effect still there, or is it just the scale that has paused?

eating slower does more than most of the supplements people recommend

Cosigning on quantity limits.

Agreed — write the application against the published criteria rather than around them.

Held the dose for an extra six weeks instead of stepping. The sulphur burps settled and I lost the same amount anyway.

Careful. A four-week stall is inside normal variation and treating it as failure is how people escalate for no reason.

nothing on this board interprets your results for you

Careful. A four-week stall is inside normal variation and treating it as failure is how people escalate for no reason.

the trend line matters more than any single value